Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 1/21/22 → 10/9/23 |
Financiación
- Lung Biotechnology PBC: 13.275,00 US$
PERFECT PH COPD: A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients with Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
- Smith, Jimmy (PI)